Clinical Trial

Contribution of Residual Tumour DNA Testing on the Surgical Bed

Study acronym: MARGINS
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate the interest of residual tumour DNA research in the operating bed after squamous cell carcinoma excision.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-06-29.
Status change: Not Yet Recruiting → Active, Not Recruiting 2025-12-29
Trial Details
NCT Number NCT05934929
Lead Sponsor Centre Henri Becquerel
Conditions Squamous Cell Carcinoma of the Oral Cavity
Enrollment 31 participants
Start Date 2024-01-08
Primary Completion 2025-12-22 (estimated)
Study Completion 2027-12-29 (estimated)
Updated on ClinicalTrials.gov 2026-01-02